1. 593: SEDATION AND NEUROMUSCULAR BLOCKADE IN ADULTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION. Issue 12 (December 2015) Authors: DeGrado, Jeremy; Anger, Kevin; Hohlfelder, Benjamin; Reardon, David; Ritchie, Brianne; Weinhouse, Gerald Journal: Critical care medicine Issue: Volume 43:Issue 12(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 593: SEDATION AND NEUROMUSCULAR BLOCKADE IN ADULTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION. Issue 12 (December 2015) Authors: DeGrado, Jeremy; Anger, Kevin; Hohlfelder, Benjamin; Reardon, David; Ritchie, Brianne; Weinhouse, Gerald Journal: Critical care medicine Issue: Volume 43:Issue 12(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (3rd December 2022) Authors: Yoshiki, Arakawa; Reardon, David; Narita, Yoshitaka; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-17. EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, FINAL RESULTS OF A MULTICENTER PHASE II STUDY. (5th November 2018) Authors: Brenner, Andrew J; Reardon, David; Wen, Patrick; Huang, Shiliang; Fox, Peter; Muzi, Mark; Lee, Eudocia Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. (5th November 2018) Authors: Prins, Robert; Mochizuki, Aaron; Orpilla, Joey; Lee, Alexander; Davidson, Tom; Gaffey, Sarah; Sanders, Catherine; Rytlewski, Julie; Ellingson, Benjamin; Li, Gang; Yong, William; Clarke, Jennifer; Arrillaga-Romany, Isabel; Colman, Howard; Reardon, David; Kaley, Thomas; de Groot, John; Liau, Linda;... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM). (5th November 2018) Authors: Khasraw, Mustafa; Weller, Michael; Estelles, David Lorente; Kolibaba, Kathryn; Lee, Chee; Gedye, Craig; De La Fuente, Macarena; Vicente, David; Reardon, David; Ojalvo, Laureen; Helwig, Christoph; Gourmelon, Carole; Groves, Morris Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ATIM-23. ANTI-CD27 AGONIST ANTIBODY VARLILUMAB IN COMBINATION WITH NIVOLUMAB FOR RECURRENT GLIOBLASTOMA (rGBM): PHASE 2 CLINICAL TRIAL RESULTS. (5th November 2018) Authors: Reardon, David; Kaley, Thomas; Iwamoto, Fabio; Baehring, Joachim; Subramaniam, Deepa; Rawls, Tracey; He, Yi; Keler, Tibor; Yellin, Michael Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ATIM-26. INTERIM RESULTS OF THE EXTENSION PHASE OF A PHASE I/IIA TRIAL OF A THERAPEUTIC CMV VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Wen, Patrick; Reardon, David; Lee, Eudocia; Iwamoto, Fabio; Anderson, David; Diaz-Mitoma, Francisco; Lassman, Andrew Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2, 3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS. (6th November 2017) Authors: Reardon, David; Desjardins, Annick; Rixe, Olivier; Cloughesy, Timothy; Alekar, Shilpa; Gamelin, Erick; Williams, Jason; Meissen, John; Taylor, Carrie; Lassman, Andrew Journal: Neuro-oncology Issue: Volume 19(2017)Supplement 6 Page Start: vi32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ATIM-38. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) + BEVACIZUMAB (BEV) IN BEV-NAÏVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). (5th November 2018) Authors: Reardon, David; Kaley, Thomas; Dietrich, Jorg; Clarke, Jennifer; Dunn, Gavin; Lim, Michael; Cloughesy, Tim; Gan, Hui; Park, Andrew; Schwarzenberger, Paul; Ricciardi, Toni; Macri, Mary; Ryan, Aileen; Venhaus, Ralph Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗